RGX-314 gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGX-314 gene therapy, covering 2025-09-17 to 2025-09-17. Get the full timeline:
Most recent: Clinical Trial Update: RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME) [Phase 2]